Increasing Cases of Chronic Hepatitis B Virus Infection in West Africa: Is Combination Therapy and Immunomodulators the Best Cure?

Abstract

West Africa has a high endemicity of chronic hepatitis B, which causes liver cancer, cirrhosis, liver failure, and chronic liver disease, all of which put a severe strain on the region's already crippled healthcare system. This disease kills nearly 200,000 people in West Africa each year. As a result, finding a cure is critical. Several scientists have developed potential treatments for this disease over the years. However, the majority of them have failed. In this paper, we shed more light on immunomodulators and combination therapy, two treatments that have shown promise in putting an end to this disease. We compared them to other modes of treatment currently available and explained why they are the best cure for chronic hepatitis B. We also encouraged the scientific community to conduct more research in this area so that better results can be realized as soon as